The resulting adipose tissue inflammation leads to a release of FFAs which activate various signaling pathways, including c-Jun N-terminal protein kinases, the inhibitor of NF-κB kinase subunit β and protein kinase R, collectively resulting in impairment of the insulin-signaling pathway, with the downstream consequence of insulin resistance and metabolic dysfunction [74]. This evidence concerns the gene INS and Insulin resistance.